GLASEEQ
LIVE

Serial Number

79236489

Owner

NOVARTIS AG

Filing Date

Jun 4, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GLASEEQ Trademark

Serial Number: 79236489 • Registration: 5609268

GLASEEQ is a trademark filed by NOVARTIS AG on June 4, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 4, 2018

Registration Date

November 20, 2018

Published for Opposition

September 4, 2018

Cancellation Date

May 7, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
May 28, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 28, 2024 DETH
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 2, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 2, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 20, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 20, 2018 R.PR
PUBLISHED FOR OPPOSITION
Sep 4, 2018 PUBO
NOTICE OF PUBLICATION
Aug 15, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2018 CNSA
ASSIGNED TO EXAMINER
Jul 27, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 20, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 13, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 12, 2018 SDRC